Conducting rate study for substance use disorder

SB 1055 requires the West Virginia Bureau for Medical Services to conduct regular, data-driven reviews of Medicaid reimbursement rates for substance use disorder services. The bill mandates that these reviews consider factors like provider costs, workforce wages, service utilization trends, geographic access, and inflation, while engaging stakeholders including treatment providers and consumer representatives. It establishes annual reporting requirements for the Bureau to share findings and methodology with the legislature, ensuring transparency in rate adjustments. This process directly affects Medicaid-funded treatment centers and aims to balance access to care with responsible fiscal management.